Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant. Bone Marrow Transplant 2008 Mar;41(5):495-503
Date
10/24/2007Pubmed ID
17952130DOI
10.1038/sj.bmt.1705888Scopus ID
2-s2.0-40749132553 (requires institutional sign-in at Scopus site) 28 CitationsAbstract
The management of acute leukaemia which relapses following an allogeneic stem cell transplant remains a major challenge. In this review we summarize the outcomes of the currently available treatment modalities and discuss emerging novel approaches.
Author List
Shaw BE, Russell NHAuthor
Bronwen E. Shaw MBChB, PhD Center Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Hematopoietic Stem Cell TransplantationHumans
Immunotherapy, Adoptive
Leukemia, Myeloid, Acute
Neoplasm, Residual
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Protein Kinase Inhibitors
Recurrence
Transplantation, Homologous